NCT07742397

Brief Summary

Falls among older adults represent a major public health burden. Approximately 30% of individuals aged 65 and older experience at least one fall each year. These events can lead not only to increased anxiety, depression, and reduced quality of life but also to serious injuries or even death. Key risk factors include muscle weakness, gait disturbances, and balance impairments. Lower limb asymmetry-referring to differences in strength, flexibility, composition, or functional capacity between the two legs-has emerged as a potentially important yet underexplored contributor to fall risk in the elderly population. While asymmetry is frequently studied in the context of sports and physical performance, where it may affect both injury risk and athletic outcomes, its implications for balance and mobility in older adults remain insufficiently investigated. This study aims to examine the relationship between lower limb asymmetries and fall risk, with the goal of identifying predictive indicators and informing the development of more effective fall prevention strategies. Ultimately, a better understanding of this relationship could contribute to improved quality of life for older adults and a reduction in healthcare costs associated with fall-related hospitalizations.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Feb 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Feb 2026Apr 2028

Study Start

First participant enrolled

February 3, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 3, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2028

Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

1.3 years

First QC Date

July 3, 2026

Last Update Submit

July 29, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Timed Up and Go (TUG) test

    A functional mobility test measuring dynamic balance and gait efficiency. Participants stand up from a chair, walk 3 meters, turn, return, and sit; longer times indicate higher fall risk.

    At baseline

  • 5-Repetition Sit-to-Stand Test (5-rep STS)

    A lower-limb strength and functional performance test. Participants rise from a chair five times as quickly as possible; slower performance reflects reduced strength and increased fall risk.

    At baseline

  • Balance test

    balance assessment is conducted using Baiobit equipment from BTS Bioengineering. The maximal balance time in monopodalic will be considered (s)

    At baseline

Secondary Outcomes (13)

  • Response time assessment

    At baseline

  • Gait Analysis

    At baseline

  • Physical Activity Questionnaire (IPAQ)

    At baseline

  • Falls Efficacy Scale-International (FES-I)

    At baseline

  • SARC-F questionnaire

    At baseline

  • +8 more secondary outcomes

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men and women between the ages of 65 yr, able to walk without assistance, lived independently, and had no major cardiovascular, muscular, skeletal or neurological conditions participated in the study.

You may qualify if:

  • Male or female, of any ethnicity.
  • Age ≥ 65 years.
  • Cognitively intact.
  • Independent ambulation.
  • Signed and accepted informed consent to participate in all procedures required for the study.

You may not qualify if:

  • Severe cardiac, pulmonary, or musculoskeletal disorders that may influence the assessment outcomes.
  • Comorbidities associated with increased fall risk, such as Parkinson's disease or stroke.
  • Body Mass Index ≥ 30.0.
  • Use of medications that affect motor coordination, balance, or bone and muscle metabolism.
  • Active oncological disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Ospedale Galeazzi-Sant'Ambrogio

Milan, Milan, Italy

RECRUITING

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2026

First Posted

August 3, 2026

Study Start

February 3, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

April 1, 2028

Last Updated

August 3, 2026

Record last verified: 2026-07

Locations